Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

GlaxoSmithKline office

GSK to fund schools science programme

March 23, 2011 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, King's College, school science

GlaxoSmithKline has followed its pledge to refund the tuition fees of UK graduates it takes on with a less direct …
News

BMS skin cancer vaccine hits phase III target

March 23, 2011 Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …
News
Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011 Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …
News

GSK Parkinson’s drug impresses at phase III

March 21, 2011 Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …
News
Obesity

Takeda obesity drug falters at phase II

March 18, 2011 Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide

Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …
News
efpia_lif_richard_bergstrom

Richard Bergström takes DG role at EFPIA

March 18, 2011 Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing

European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …
Appointment

Biotech lobbies for further UK tax breaks

March 17, 2011 Research and Development BIA, R&D tax credits, biotech

Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …
News
merck_sharp_dohme_deepak_khanna

MSD’s Deepak Khanna to chair American Pharmaceutical Group

March 17, 2011 Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …
Appointment
novartis

Novartis to close UK manufacturing site, research downsized

March 16, 2011 Research and Development Horsham, Novartis, respiratory

Novartis is to close its manufacturing site in Horsham, West Sussex, but will retain its work in respiratory research at …
News
Novarits

Novartis to close UK research site

March 16, 2011 Research and Development Horsham, Novartis, job cuts, pharma job cuts

[UPDATE: Novartis has confirmed it will close its manufacturing site in Horsham, but continue to conduct respiratory research at the site …
News

New Regulatory & Pharmacovigilance training webinars available

March 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wainwright Associates have designed a multitude of courses on general and specific regulatory & pharmacovigilance topics including:• Analytical Validation• Appeals, Hearings and …
News
Press release
Pfizer's Sandwich research facility

Pfizer’s CRO plans for Sandwich will have limited impact

March 15, 2011 Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts

Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …
News

Bayer-helmed oncology biomarker project launched

March 14, 2011 Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
News

Diabetes trial disappointment for GSK and Tolerx

March 14, 2011 Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes

GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …
News

Former Gates Foundation director joins Sanofi

March 14, 2011 Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development

Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026